Answers are grounded in this paper and cite their sources.
The paper deals with international guidelines for the management of antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitides (SVs) that are a group of severe life-threatening immune-mediated diseases. This group includes granulomatosis with polyangiitis (Wegener's granulomatosis), microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis (Churg-Strauss). ANCA-associated SVs (ANCA-SVs) are an important problem of practical rheumatology. The guidelines for the management of ANCA-SV, which were published by the International Group of Experts, which summarize modern scientific achievements and international clinical experience, currently remain the basis for treatment of these diseases.
No takes yet. Share an insight, caveat, or question.
Т. V. Beketova (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: